文献速递细菌感染、耐药与抗菌药物

公开可得的艰难梭菌基因组序列中抗菌治疗药物耐药遗传决定因素罕见

Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
PubMed 文献 · J Antimicrob Chemother · 2024-01-01

该研究扫描了EnteroBase平台26 557株艰难梭菌基因组序列,检测万古霉素、非达霉素和甲硝唑耐药相关遗传决定因素,并对143株分离株测定药敏。结果显示治疗药物耐药遗传决定因素总体罕见,pCD-METRO质粒仅见于2008年德国一株临床分离株,pX18-498质粒局限于美国近期相关分离株。

要点

  • 万古霉素和甲硝唑敏感性降低相关突变频率在2000年后升高,近期又急剧下降。
  • 非达霉素耐药相关突变见于多个主要基因型,但未发现耐药克隆的国际传播。
  • 现有公共耐药标记数据库无法检测大多数与CDI抗生素治疗相关的遗传决定因素。

核心结论

  • 基因组数据提示艰难梭菌对治疗用抗菌药物的耐药罕见。
  • 公共耐药标记数据库无法检测大多数与CDI抗生素治疗相关的遗传决定因素。

研究设计与样本

  • 扫描EnteroBase平台公开可得的26 557株艰难梭菌基因组序列中的质粒、点突变和基因截短。
  • 对143株选定的艰难梭菌分离株测定抗菌药物敏感性。

主要发现

  • 导致万古霉素和甲硝唑敏感性降低的突变频率在2000年后强烈升高,最高达所有测序艰难梭菌基因组的52%。
  • 上述两种突变近期均急剧下降,反映了CDI流行病学的重大变化。
  • 在多个主要基因型中检测到与非达霉素耐药相关的突变,但未发现耐药克隆国际传播的证据。
  • 赋予甲硝唑耐药的pCD-METRO质粒仅在一株2008年德国医院患者分离的既往未报告艰难梭菌分离株中检出。
  • 推定与万古霉素敏感性降低相关的pX18-498质粒局限于美国近期相关分离株。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the frequencies and clonal distributions of putative genetic determinants of resistance to antimicrobials applied for treatment of Clostridioides difficile infection (CDI), as documented in the genomic record. METHODS: We scanned 26 557 C. difficile genome sequences publicly available from the EnteroBase platform for plasmids, point mutations and gene truncations previously reported to reduce susceptibility to vancomycin, fidaxomicin or metronidazole, respectively. We measured the antimicrobial susceptibility of 143 selected C. difficile isolates. RESULTS: The frequency of mutations causing reduced susceptibility to vancomycin and metronidazole, respectively, increased strongly after 2000, peaking at up to 52% of all sequenced C. difficile genomes. However, both mutations declined sharply more recently, reflecting major changes in CDI epidemiology. We detected mutations associated with fidaxomicin resistance in several major genotypes, but found no evidence of international spread of resistant clones. The pCD-METRO plasmid, conferring metronidazole resistance, was detected in a single previously unreported C. difficile isolate, recovered from a hospital patient in Germany in 2008. The pX18-498 plasmid, putatively associated with decreased vancomycin susceptibility, was confined to related, recent isolates from the USA. Phenotype measurements confirmed that most of those genetic features were useful predictors of antibiotic susceptibility, even though ranges of MICs typically overlapped among isolates with and without specific mutations. CONCLUSIONS: Genomic data suggested that resistance to therapeutic antimicrobial drugs is rare in C. difficile. Public antimicrobial resistance marker databases were not equipped to detect most of the genetic determinants relevant to antibiotic therapy of CDI.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Kolte B, Nübel U. Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences. J Antimicrob Chemother. 2024. PMID: 38598696. doi:10.1093/jac/dkae101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。